QMatter, Inc.

Biotech London, X0

About

Issuer

Entity type
Corporation
Jurisdiction
Delaware
Sector
Biotech
Headquarters
London, X0
Street
10 South Hill Park, First Floor Flat
Zip
NW3 2SB

Offering

Total offering
$1.2M
Amount sold
$1.2M
First sale
Mar 26, 2026
Min investment
$1
Securities
Equity
Federal exemption
Rule 506(b)
Investors so far
4

How this filing compares

Ranked #32 of 47 Biotech filings in April 2026 by offering amount.

Median Biotech filing in April 2026: $3M. This offering is 0.4× the median.

Other X0 filings this week: Blue Spark Energy Systems Inc., Skerryvore Global Emerging Markets Equity Fund LP, EnteroBiotix LTD, TAG Capital Group Ltd., RheEnergise Ltd

Leadership

Alexis Ralli — Executive Officer (also: Director)

Blair Robertson — Director

Owen Lozman — Director

Timothy Weaving — Director

Filing details

QMatter, Inc. filed a Form D with the SEC on April 9, 2026.

Other newest Biotech companies

Other newest companies in X0